Tortoise Investment Management LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, Holdings Channel reports. The firm purchased 407 shares of the medical equipment provider’s stock, valued at approximately $381,000.

Several other institutional investors have also recently made changes to their positions in the stock. Wedbush Securities Inc. boosted its stake in Intuitive Surgical by 1.0% in the second quarter. Wedbush Securities Inc. now owns 1,871 shares of the medical equipment provider’s stock valued at $1,750,000 after buying an additional 19 shares in the last quarter. Traynor Capital Management Inc. boosted its stake in Intuitive Surgical by 29.4% in the second quarter. Traynor Capital Management Inc. now owns 1,681 shares of the medical equipment provider’s stock valued at $1,566,000 after buying an additional 382 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its stake in Intuitive Surgical by 4.9% in the second quarter. DekaBank Deutsche Girozentrale now owns 15,208 shares of the medical equipment provider’s stock valued at $14,292,000 after buying an additional 709 shares in the last quarter. First Trust Advisors LP boosted its stake in Intuitive Surgical by 219.1% in the second quarter. First Trust Advisors LP now owns 31,672 shares of the medical equipment provider’s stock valued at $29,625,000 after buying an additional 21,746 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. boosted its stake in Intuitive Surgical by 2.5% in the second quarter. Schwab Charles Investment Management Inc. now owns 118,345 shares of the medical equipment provider’s stock valued at $110,697,000 after buying an additional 2,904 shares in the last quarter. 96.84% of the stock is owned by institutional investors.

Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at 942.25 on Friday. Intuitive Surgical, Inc. has a 52 week low of $610.71 and a 52 week high of $974.66. The company has a 50-day moving average of $941.15 and a 200-day moving average of $833.76. The firm has a market cap of $35.00 billion, a price-to-earnings ratio of 45.13 and a beta of 0.39. Intuitive Surgical’s stock is set to split on the morning of Thursday, August 31st. The 3-1 split was announced on Friday, August 11th. The newly issued shares will be payable to shareholders after the closing bell on Wednesday, August 30th.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 EPS for the quarter, topping the consensus estimate of $5.79 by $0.16. The business had revenue of $756.20 million for the quarter, compared to analyst estimates of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The company’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.62 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post $23.86 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.dailypolitical.com/2017/08/13/tortoise-investment-management-llc-invests-381000-in-intuitive-surgical-inc-nasdaqisrg.html.

Several research firms recently commented on ISRG. BidaskClub cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. Canaccord Genuity reaffirmed a “hold” rating and issued a $1,000.00 price objective (up from $870.00) on shares of Intuitive Surgical in a research report on Wednesday, July 26th. Morgan Stanley reaffirmed an “overweight” rating and issued a $1,070.00 price objective (up from $950.00) on shares of Intuitive Surgical in a research report on Tuesday, July 25th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $1,067.00 price objective on the stock in a research report on Tuesday, July 25th. Finally, Citigroup Inc. reissued a “buy” rating and set a $1,078.00 price target (up from $917.00) on shares of Intuitive Surgical in a research report on Monday, July 24th. Seven research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $980.03.

In other news, VP Jamie Samath sold 242 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $949.01, for a total value of $229,660.42. Following the sale, the vice president now owns 23 shares of the company’s stock, valued at $21,827.23. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Mark J. Meltzer sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $887.09, for a total transaction of $2,661,270.00. Following the completion of the sale, the senior vice president now directly owns 3,046 shares in the company, valued at approximately $2,702,076.14. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,065 shares of company stock worth $31,659,090. Insiders own 2.50% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.